CLERICO, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 120
EU - Europa 82
AS - Asia 54
Totale 256
Nazione #
US - Stati Uniti d'America 120
IT - Italia 32
SG - Singapore 23
SE - Svezia 18
IE - Irlanda 17
CN - Cina 10
IN - India 10
CZ - Repubblica Ceca 5
DE - Germania 4
ID - Indonesia 3
KR - Corea 3
FI - Finlandia 2
HK - Hong Kong 2
UA - Ucraina 2
VN - Vietnam 2
FR - Francia 1
GB - Regno Unito 1
IR - Iran 1
Totale 256
Città #
Chandler 23
Singapore 18
Dublin 17
Fairfield 11
Ashburn 9
Chennai 8
Nyköping 8
Turin 8
Brno 5
Houston 5
Ann Arbor 4
Cambridge 4
Naples 4
Torino 4
Washington 4
Boston 3
Genoa 3
Hangzhou 3
Hebei 3
Jakarta 3
Munich 3
Seoul 3
Guiyang 2
Lappeenranta 2
Medford 2
Princeton 2
Rome 2
San Diego 2
Seattle 2
Somma Lombardo 2
Wilmington 2
Aiello Del Sabato 1
Bayreuth 1
Beijing 1
Dallas 1
East Brunswick 1
Milan 1
Nanjing 1
Norwalk 1
Pune 1
San Mateo 1
Syracuse 1
Upper Marlboro 1
Totale 183
Nome #
Real life use of bendamustine in elderly patients with lymphoid neoplasia 83
COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment 57
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma 53
HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience 32
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up 22
Non-Hodgkin lymphoma treated with anti-CD20 antibody-based immunochemotherapy 20
Totale 267
Categoria #
all - tutte 1.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/202264 8 5 3 5 5 2 4 2 3 6 11 10
2022/202384 4 3 1 6 16 31 4 5 8 0 5 1
2023/202456 5 9 4 0 1 8 4 3 1 2 5 14
2024/202531 3 13 11 4 0 0 0 0 0 0 0 0
Totale 267